What initial change can a pharmacist suggest if a patient reports significant GI adverse effects (AEs) associated with oral ferrous salts? A. Switch to an intravenous formulation B. Switch to a subcutaneous formulation C. Switch to a slow-release formulation D. Take half the dose twice daily
[Answered]: What initial change can a pharmacist suggest if a…
Need help with your Clinical Case Studies case study or NCLEX preparation? Connect with a verified Nursing expert now.